| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | JQ-1 | GDSC1000 | pan-cancer | AAC | -0.0017 | 1 |
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | -0.0015 | 1 |
| mRNA | neratinib | CTRPv2 | pan-cancer | AAC | -0.0017 | 1 |
| mRNA | B02 | CTRPv2 | pan-cancer | AAC | 0.0017 | 1 |
| mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | 0.0015 | 1 |
| mRNA | BRD-K27188169:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0021 | 1 |
| mRNA | STF-31 | CTRPv2 | pan-cancer | AAC | -0.0014 | 1 |
| mRNA | PRL-3 Inhibitor I | CTRPv2 | pan-cancer | AAC | -0.0014 | 1 |
| mRNA | AZD1480 | CTRPv2 | pan-cancer | AAC | 0.002 | 1 |
| mRNA | BRD-K19103580 | CTRPv2 | pan-cancer | AAC | 0.0013 | 1 |